Eli Lilly & Co. (LLY)
1444.57
+17.29
(+1.21%)
USD |
NYSE |
Nov 13, 16:00
1442.00
-2.57
(-0.18%)
After-Hours: 17:13
Eli Lilly Price to Book Value : 33.76 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 33.36 |
| November 11, 2026 | 33.59 |
| November 10, 2026 | 33.48 |
| November 09, 2026 | 33.00 |
| November 06, 2026 | 31.65 |
| November 05, 2026 | 31.90 |
| November 04, 2026 | 33.14 |
| November 03, 2026 | 32.94 |
| November 02, 2026 | 32.98 |
| October 30, 2026 | 33.13 |
| October 29, 2026 | 32.11 |
| October 28, 2026 | 30.11 |
| October 27, 2026 | 29.96 |
| October 26, 2026 | 29.90 |
| October 23, 2026 | 29.76 |
| October 22, 2026 | 30.54 |
| October 21, 2026 | 29.70 |
| October 20, 2026 | 30.00 |
| October 19, 2026 | 28.99 |
| October 16, 2026 | 29.38 |
| October 15, 2026 | 29.25 |
| October 14, 2026 | 28.25 |
| October 13, 2026 | 27.26 |
| October 12, 2026 | 27.64 |
| October 09, 2026 | 27.56 |
| Date | Value |
|---|---|
| October 08, 2026 | 27.34 |
| October 07, 2026 | 27.78 |
| October 06, 2026 | 27.05 |
| October 05, 2026 | 26.72 |
| October 02, 2026 | 26.71 |
| October 01, 2026 | 26.87 |
| September 30, 2026 | 27.04 |
| September 29, 2026 | 32.92 |
| September 28, 2026 | 32.93 |
| September 25, 2026 | 32.89 |
| September 24, 2026 | 32.84 |
| September 23, 2026 | 31.99 |
| September 22, 2026 | 32.52 |
| September 21, 2026 | 32.37 |
| September 18, 2026 | 32.04 |
| September 17, 2026 | 32.03 |
| September 16, 2026 | 31.62 |
| September 15, 2026 | 31.57 |
| September 14, 2026 | 31.63 |
| September 11, 2026 | 31.01 |
| September 10, 2026 | 31.21 |
| September 09, 2026 | 31.24 |
| September 08, 2026 | 31.23 |
| September 04, 2026 | 31.94 |
| September 03, 2026 | 32.23 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.444 |
| Merck & Co., Inc. | 8.118 |
| Pfizer Inc. | 1.851 |
| Bristol Myers Squibb Co. | 5.540 |
| Structure Therapeutics, Inc. | 1.168 |
Price to Book Value Related Metrics
| PE Ratio | 47.46 |
| PS Ratio | 15.15 |
| PEG Ratio | 0.9391 |
| Price to Free Cash Flow | 112.08 |
| Price | 1444.57 |
| Earnings Yield | 2.11% |
| Market Cap | 1.360T |
| PEGY Ratio | 0.9304 |
| Operating PE Ratio | 29.57 |
| Normalized PE Ratio | 38.44 |